Jimmy Lin

Title: The Innovative Contributions of Jimmy Lin

Introduction

Jimmy Lin is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research, particularly in understanding the genetic landscape of human breast and colorectal cancers. His work has implications for diagnostic and therapeutic interventions.

Latest Patents

Jimmy Lin holds a patent titled "Consensus coding sequences of human breast and colorectal cancers." This patent details an analysis of 13,023 genes in 11 breast and 11 colorectal cancers. The findings reveal that individual tumors accumulate an average of approximately 90 mutant genes, with a subset of these contributing to the neoplastic process. By applying stringent criteria, Lin and his team identified 189 genes that were mutated at significant frequency, which were previously unknown to be genetically altered in tumors. These genes are predicted to affect various cellular functions, including transcription, adhesion, and invasion. This research defines the genetic landscape of two human cancer types and provides new targets for diagnostic and therapeutic intervention and monitoring. He has 1 patent to his name.

Career Highlights

Jimmy Lin is affiliated with The Johns Hopkins University, where he conducts his research. His work has garnered attention for its innovative approach to understanding cancer genetics and its potential impact on treatment strategies.

Collaborations

Some of his notable coworkers include Tobias Sjoblom and Sian Jones, who have collaborated with him on various research projects.

Conclusion

Jimmy Lin's contributions to cancer research through his innovative patent and collaborative efforts highlight the importance of understanding genetic mutations in cancer. His work continues to pave the way for advancements in diagnostic and therapeutic approaches.